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Coronavirus N is a multifunctional protein that plays an essential role in enhancing the efficiency of 
virus transcription and assembly. This manuscript reports the analysis of HCoV-NL63 N protein by 
comparing the amino acid sequences of coronavirus N-homologues. A ~50 kDa protein was expressed 
in both a mammalian cell and bacterial cell system that is similar in size to the predicted ~42.6 kDa 
HCoV-NL63 N protein. PSORTII identified two putative nuclear localisations signals and PONDR 
identified one disordered region in HCoV-NL63 N. The reported protein analysis serves as a prelude to 
laboratory analysis to understand the processing of HCoV-NL63 N. 
 
Key words: HCoV-NL63, nucleocapsid protein, protein analysis, nuclear localisation signals, protein 
ordered/disordered regions. 
 
 
INTRODUCTION 
 
Genome sequencing technologies have resulted in large 
genome databases and the rate of genome sequencing 
has surpassed our ability to determine the function of the 
proteins these genomes encode. In silico analysis 
provides tools to predict possible functions of these 
proteins by comparing novel proteins of unknown function 
with proteins of known function, or by analyzing the 
unknowns using an algorithm based on information from 
proteins of known function. Thus, the theoretical analysis 
of proteins provide a useful framework that has given 
researchers the ability to predict the function of these 
proteins, which can then be verified with the use of in 
vitro and in vivo studies (MacKenzie et al., 2008; 
Mahotka et al., 2002). Coronaviruses are enveloped 
viruses of the Coronaviridae family in the order 
Nidovirales. Recently, the International Committee for 
Taxonomy of Viruses (ICTV) reported that the three 
traditional coronavirus groups are replaced by four 
genera, namely Alphacoronaviruses,  Betacoronaviruses,  
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Gammacoronaviruses and Deltacoronaviruses (http:// 
talk.ictvonline.org/files/ictv_documents/m/msl/4090.aspx). 
Coronaviruses have single-stranded, positive sense RNA 
genomes, ranging in size from 25 to 30 kbs.The genomes 
typically encode for four structural proteins, spike (S), 
envelope (E), membrane (M) and nucleocapsid (N). The 
coronavirus N protein is one of the most abundantly 
produced viral proteins within an infected cell. This 
protein has been shown to have several functions, 
including binding to viral RNA to form the 
ribonucleocapsid and is proposed to have roles in 
replication, transcription and translation. To date, 
coronavirus N proteins have been shown to cause 
deregulation of the host cell-cycle (Surjit et al., 2006; 
Wurm et al., 2001), inhibit the production of interferon 
(Kopecky-Bromberg et al., 2007), up-regulate the 
production of COX2 (Yan et al., 2006), up-regulate AP1 
activity (He et al., 2003), induce apoptosis in serum 
starved COS1-cells (Surjit et al., 2004a) and interact with 
various cellular proteins including cyclophilin A (Luo et 
al., 2004) and hnRNP-A1 (Luo et al., 2005; Wang and 
Zhang, 1999), which may have possible pathological 
consequences. 
Even though several studies  have  shown  that  the  N- 
 
 
 
 
protein of members of Nidovirales localizes to the 
nucleus and/or nucleolus (Cawood et al., 2007; Hiscox et 
al., 2001; Timani et al., 2005; Wurm et al., 2001), others 
have shown that N localizes predominantly or exclusively 
to the cytoplasm (Rowland et al., 2005; Stohlman et al., 
1983; You et al., 2005). This indicates that the 
localization of N to the nucleus or nucleolus is not a 
conserved property of nidoviruses (Rowland et al., 2005). 
The N-protein of coronaviruses is highly antigenic and 
reliably induces an antibody response (Mourez et al., 
2007) and has therefore been recognized as an important 
target in the development of coronavirus diagnostics 
(Blanchard et al., 2011; Lee et al., 2008).  
HCoV-NL63 was first isolated from the nasopharyngeal 
aspirate of a 7 month old infant from Holland (van der 
Hoek et al., 2004). The virus has since been shown to 
have a global distribution and is observed primarily in the 
winter season in temperate climates. To date, the virus 
has been associated with acute respiratory illness and 
croup in young children, the elderly and 
immunocompromised individuals (Oosterhof et al., 2010; 
Sung et al., 2010; van der Hoek et al., 2005, 2006). 
Clinical manifestations most frequently associated with 
HCoV-NL63 infections include cough, coryza, fever, sore 
throat, bronchiolitis, bronchitis, croup and pneumonia 
(Fielding, 2011; van der Hoek, 2007). To date, three 
groups have reported a fatal outcome following HCoV-
NL63 infection, indicating that this virus could be involved 
in more severe respiratory tract disease (Bastien et al., 
2005; Cabeca and Bellei, 2012; Oosterhof et al., 2010); 
all of these cases had underlying suppressed or 
compromised immune systems.  
Unfortunately, the virus is not well studied at a 
molecular level with only the spike (Lin et al., 2008, 2011; 
Mathewson et al., 2008) and ORF3 proteins (Fielding and 
Suliman, 2009; Muller et al., 2010) previously 
characterized. In this work, the HCoV-NL63 N was 
expressed in mammalian and bacterial systems. Various 
bioinformatics tools were used to analyze the HCoV-
NL63 N amino acid sequence. The importance of 
identified putative nuclear localization signals and 
disordered motifs were discussed. This manuscript 
reports the analysis of HCoV-NL63 N as a prelude to the 
molecular characterization of N in in vitro mammalian and 
bacterial cell systems. 
 
 
RESULTS AND DISCUSSION 
 
The HCoV-NL63 genome is approximately 27 553 
nucleotides in size, with the typical coronavirus genome 
organization. It produces six separate mRNAs, with all 
potential ORFs encoding for viral proteins. N is 
expressed from distinct subgenomic (sg) mRNA 6, the 
most abundant sg mRNA (Pyrc et al., 2004). To 
determine the size of HCoV-NL63 N, recombinant GST-N 
was   expressed   in   a   bacterial   system,   purified    by 
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affinity column and treated with TEV to remove the GST-
tag, according to the manufacturer’s specification 
(Promega). Also, recombinant HCoV-NL63 N-HA was 
transfected and expressed in Cos-7 cells (Khan et al., 
2006). SDS-PAGE analysis of purified bacterial 
expressed protein (Figure 1A) and Western Blot analysis 
of total mammalian cell lysate (Figure 1B) showed ~50 
kDa proteins which is larger than the size of the 42.6 kDa 
protein predicted by our initial analysis 
(http://www.sciencegateway.org/tools/ proteinmw.htm). 
This discrepancy in size showed that the protein was 
probably pre-, co- or post-translationally modified; the 
type of modification is currently being investigated. 
Next, the amino acid sequence of HCoV-NL63 N was 
compared to other coronavirus N proteins (Table 1). 
HCoV-NL63 was shown to be most similar to the human 
coronavirus 229E N (43% identity; 63% similarity). This 
was not totally unexpected, since previous molecular 
clock analysis estimate that HCoV-NL63 and HCoV-229E 
evolved from a most recent common ancestor in the 11
th
 
century (Pyrc et al., 2006). Interestingly, HCoV-NL63 N 
also showed high amino acid similarity to the bat 
coronavirus HKU7 N (40% identity; 57% similarity). As 
speculated previously (Fielding and Suliman, 2009), this 
high amino acid similarity raises interesting questions 
about the relationship between this human and bat 
coronaviruses. Woo and colleagues postulate that the 
ancestor of all present-day coronaviruses infected a bat 
and then jumped from that bat to a bird, or alternatively, 
first infected a bird and then jumped to a bat, evolving 
dichotomously. This bat coronavirus then jumped to 
another bat species, which in turn jumped to other bat 
species or other mammals, including humans. Each of 
these interspecies jumps resulted in the independent 
evolution of these coronaviruses and gave rise to the 
current coronavirus genera. In fact, present evidence 
suggests that the huge diversity of coronaviruses in bats 
make them excellent gene pools for group 1 and group 2 
coronaviruses (Woo et al., 2009).  
Comparative analysis using CLUSTAL X version 2.0 
(Larkin et al., 2007) of 10 coronavirus species identified a 
9 amino acid region conserved between the N 
homologues, that is FYY(L/T)GTGP (Figure 2). 
Conserved regions within a family of proteins is 
commonly indicative of structural and functional 
conservation, as well as an evolutionary relationship. The 
function of this sequence, if any, is yet to be elucidated. 
Since interactions between coronavirus RNA and N are 
assumed to predominantly take place at the nucleocapsid 
N-terminal domain, the possible role of this conserved 
motif in RNA-N interaction will be studied. However, 
several other binding sites within N have also previously 
been identified, indicating that both N- and C-terminal 
domains are probably involved in RNA binding (Chang et 
al., 2009).  
Translocation of proteins from the cytoplasm through 
the nuclear pore  complex  and  into  the  nucleoplasm  is  
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Figure 1. Expression of HCoV-NL63 N in: (A) a bacterial cell system. Cleavage of the GST-tag 
from SARS-CoV and HCoV-NL63 full length N using ProTEV protease (Promega). SARS-CoV N 
and NL63 N were reverse transcribed from viral RNA and PCR amplified using nucleocapsid 
specific primers. The N-gene was cloned into the pFlexi™ protein expression vector (Promega), 
which appends an N-terminal GST affinity tag. Protein expression was induced by addition of 
0.1% Rhamnose (Promega). Lane 1: Pre-stained molecular weight protein marker; Lane 2: 
SARS-CoV GST-N; Lane 3: SARS-CoV N with GST cleaved; Lane 4: HCoV-NL63 GST-N; Lane 
5: HCoV-NL63 N with GST cleaved. SARS-CoV N was included as a control. (B) a mammalian 
cell system. Recombinant plasmid pCAGGS-N-HA (HCoV-NL63 N gene cloned into vector 
pCAGGS which appends an N-terminal Haemagglutinin tag to expressed protein) was 
transfected with Lipofectamine 2000 (Invitrogen) into a COS-7 cell line (African green monkey 
cells) and grown at 37°C in 5% CO2 for 16 h. Cells were then lysed and the target protein 
detected on a Western Blot using rabbit anti-HA polyclonal (1:250) as primary antibody and goat 
anti-Rabbit polyclonal secondary antibody (1:1000).  
 
 
 
initiated by nuclear localization signals (NLSs) on the 
protein binding to a NLS-binding site on importin-α of the 
host cell (Rowland et al., 2005). NLSs are rich in basic 
amino acids and conform to one of three types, that is, (i) 
monopartite pat4, (ii) monopartite pat7 or (iii) 
bipartitemotifs. Pat4 NLSs are recognized by the 
presence of 4 basic residues - either K or R or the 
presence of 3 basic residues (K/R) and/or (H/P). Pat7 
NLSs are segments beginning with P and followed within 
3 residues by a basic segment containing 3 K or R 
residues out of 4. On the other hand, bipartite NLSs 
begin with 2  basic  residues,  followed  by  a  10  residue 
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Table 1. Comparison of HCoV-NL63 N amino acid sequence to homologues from selected coronavirus isolates. Identity values 
(%) are shown in BOLD and similarity values (%) are shown in ITALICS. 
 
Coronavirus SARS MHV IBV OC43 229E TGEV PEDV HKU1 HKU7 
NL63 
21 18 17 18 43 32 35 20 40 
34 31 31 32 63 51 50 34 57 
 
To identify homologues, the amino acid sequence of HCoV-NL63 N was compared to sequences in the GenBank database at the 
National Centre for Biotechnology by using the Basic Blast Search Server (Altschul et al., 1990). Subsequently, HCoV-NL63 N was 
aligned with selected coronavirus N proteins with CLUSTAL X version 2 (Larkin et al., 2007). The sequences aligned, with Genbank 
accession numbers in bold, were: HCoV-NL63: NL63 (DQ846901.1); SARS-CoV: SARS (AY360146.1); Mouse Hepatitis Virus: MHV 
(AAU06361); Infectious Bronchitis Virus: IBV (AAA46214), Human coronavirus OC43: HCoV-OC43 (AY585229.1); HCoV-229e: 229E 
(AAG48597); Transmissible gastroenteritis virus: TGEV (AAA47915); Porcine epidemic diarrhea virus:PEDV (AF353511); Human 
coronavirus HKU1: HKU1 (AAT98585) and Bat coronavirus HKU7: HKU7 (DQ666343). 
 
 
 
 
  
 
 
 
Figure 2. Comparative analyses of HCoV-NL63 N. Selected HCoV-NL63 N-homologues were aligned with CLUSTAL X version 2.0 (Larkin et 
al. 2007) and viewed with GENEDOC version 2.6.002 software (Nicholas et al; 1997). Shading indicates conserved regions and gaps were 
introduced to align sequences. Conserved region identified: (i) FYY(L/T)GTGP. N amino acid sequences were obtained from NCBI 
(accession numbers in brackets): HCoV-NL63 (DQ846901.1), SARS-CoV (AY360146.1), MHV (AAU06361), IBV (AAA46214), HCoV-OC43 
(AY585229.1), HCoV-229E (AAG48597), TGEV (AAA47915), PEDV (AF353511), HKU1 (AAT98585) and HKU7 (DQ666343).  
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Figure 2. Continued.  
 
 
 
spacer, which is then followed by another basic region 
composed of 3 basic residues out of 5 residues. PSORT 
II (http://www.genscript.com/psort/psort2.html) identified 
two possible NLSs for HCoV-NL63 N. A predicted pat4 
motif was identified at amino acid position 232-235 
(KKPR) and a predicted pat7 motif at position 234-240 
(PRWKRVP); no bipartite motifs were identified for NL63 
N-protein.  
Predictors of Natural Disordered Regions (PONDR) 
was used to predict possible disordered regions within 
HCoV-NL63 N. PONDR (http://www.pondr.com) uses 
several algorithms, including VL-XT, XL1-XT, VL3 and 
VSL1 to predict possible disordered regions. In this study, 
the VL-XT and VSL1 algorithms were used. VL-XT 
incorporates 3 feed-forward neural networks which are 
based on long disordered regions characterized by x-ray 
chrystallographic data (Li et al., 1999; Romero et al., 
1997, 2001). The VSL1 utilizes two algorithms for short (< 
30aa) and long (> 30aa) disordered regions and is trained 
on 1335 protein sequences (Obradovic et al., 2005). 
Even though in silico analysis is a good predictor of 
protein structure, errors can occur and findings must be 
substantiated with experimental evidence. The 
order/disorder state of HCoV-NL63 N was different to that 
of other coronavirus N-proteins, with HCoV-NL63 N 
having only one disordered region (residues 109 to 248) 
compared to the 2 to 3 disordered regions within other 
coronavirus N-proteins (Chen et al., 2005). Interestingly, 
many of the motifs and/or regions important for the 
interaction of SARS-CoV N with other proteins fall within 
these disordered regions (He et al., 2004; Huang et al., 
2004; Luo et al., 2004; Surjit et al., 2004b). For this 
reason, residues 109 to 248 of HCoV-NL63 N could be 
crucial for  interactions  between  HCoV-NL63  and  other  
proteins.  
In this study, molecular and bioinformatics tools were 
used to analyse HCoV-NL63 nucleocapsid protein by 
comparing it to selected coronavirus N proteins. Putative 
motifs that could be essential for the functioning of this 
protein have been identified; these are currently being 
verified in our laboratory. To our knowledge, this is the 
first manuscript reporting the molecular analysis of 
HCoV-NL63 N.  
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